MEDIFIRST SOLUTIONS, INC. ANNOUNCES UPDATE ON FDA SUBMISSION
February 11 2016 - 10:30AM
InvestorsHub NewsWire
Freehold, NJ -- February 11, 2016 -- InvestorsHub NewsWire
-- MEDIFIRST SOLUTIONS, INC. (OTCQB:
MFST) (the “company” or “Medifirst”) would like to update
shareholders on the progress of its 510(k) submission to the Food
and Drug Administration (FDA). Commented CEO Bruce J. Schoengood,
“We are pleased to inform our shareholders that The Time Machine
Infrared Laser System is in the final stages of review for 510(k)
approval.” Working with Medifirst’s FDA consulting firm, the
company is progressing to gather the information and reports
necessary to respond to the request for additional information
regarding the hand-held laser system received from the FDA. The
deadline for the company to respond is June 2016, but Medifirst
anticipates it will have the response completed within the next
eight weeks. Upon the completion of the review process to the
satisfaction of the FDA, and being awarded 510(k) clearance,
Medifirst will begin to sell its laser units across the United
States. The company believes that the approval will also jump-start
international sales for several distributors in South America and
Europe.
Driven by the huge demand for minimally invasive skin and pain
treatments, the global market for medical and therapeutic lasers
have been estimated to grow as high as to $4 billion in 2015.
Continued CEO Schoengood, “This technology represents huge
potential growth for the company and we have assembled a team of
industry professionals that have assisted in the FDA process. The
FDA request for additional information is a common request and we
are very excited to complete the process. We appreciate the support
and patience of our shareholders and the company will be updating
shareholders on company events and progress on a regular basis.”
Medifirst believes that the laser devices are very unique and offer
an easy-to-use, mobile, affordable and effective product for many
different health care professionals.The Time Machine Laser System
can serve to enhance their current treatment protocols, as well as
produce additional revenue streams from the treatment range
Medifirst believes The Time Machine Infrared Laser System is
capable of delivering to such health care professionals. Please
visit www.medifirstsolutions.com and the Medifirst social media
pages for more information.
Contact: Investor Relations
Phone: (732) 786-8044
Email:
info@medifirstsolutions.com
Website: www.medifirstsolutions.com
About the Lasers
Medical Lasers Manufacturer, Inc. (“MLM”), a Medifirst subsidiary,
will specialize in producing high quality diode-pumped solid-state
lasers. The laser division, including products and treatment
programs, will be operated out of MLM. The company’s focus is to
help patients with specific cosmetic skin conditions, as well as
relief of muscle and joint pain and muscle spasm and inflammation.
MLM’s manufacturer consists of a group of engineers with decades of
experience in laser research and manufacturing that have been
providing customized laser products to a wide variety of
universities and labs.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is
headquartered in New Jersey. The company seeks innovative medical
and healthcare products and technologies which are targeted to both
medical and healthcare professionals, as well as everyday
consumers. Medifirst is developing and establishing both consumer
and professional medical cliental that can serve as a pipeline that
will allow for distribution of future products and services. For
more details visit www.medifirstsolutions.com for more
information.
# # #
Forward-Looking Statements: The statements in this press
release that relate to the company's expectations with regard to
the future impact on the company's results from new products in
development are forward-looking statements, and may involve risks
and uncertainties, some of which are beyond our control. Such
risks and uncertainties are described in greater detail in our
filings with the U.S. Securities and Exchange Commission.
Since the information in this press release may contain statements
that involve risk and uncertainties and are subject to change at
any time, the company's actual results may differ materially from
expected results. We make no commitment to disclose any
subsequent revisions to forward-looking statements.